1-(4-isopropylphenyl)propan-1-ol | 4397-08-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 1-(4-isopropylphenyl)propan-1-ol
• 英文别名: 1-(4-Isopropylphenoxy)propanol；4-isopropyl-α-ethyl-benzenemethanol；1-(4-propan-2-ylphenyl)propan-1-ol
• CAS: 4397-08-4
• 化学式: C₁₂H₁₈O
• 分子量: 178.274
• InChiKey: NUNYALSGVAYXDW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(4-isopropylphenyl)propan-1-ol 以91%的产率得到
  参考文献：
  名称：

  Jia Weimin, Song Shuzhong, Xin Qingfu, Pan Guizhi, Huaxue shiji (Chem. Reagents), 16 (1994) N 1, S 22-24

  摘要：

  DOI：
• 作为产物：
  描述：

  1-(4-异丙基苯基)丙烷-1-酮 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 反应 0.5h， 生成 1-(4-isopropylphenyl)propan-1-ol
  参考文献：
  名称：

  Benzofurans as suppressors of neurodegeneration

  摘要：

  该化合物的化学式为：其中R1和R2分别为H或可被取代的碳氢基团，或者R1和R2形成一个3至8个成员的碳氢或杂环环，该环可能被取代；R3为H，一个可被取代的低碳基或一个可被取代的芳香基；R4为(1)一个可被取代的芳香基，(2)一个被可被取代的芳香基取代的脂肪烃基，该烃基可能被进一步取代，或者(3)一个酰基；X和Y分别为氧或硫，可能被氧化；环A为一个苯环，可能被进一步取代，或者其盐，可用作抑制神经退化的药物。

  公开号：

  US07008950B1

文献信息

• Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors
  作者：Hiroshi Enomoto、Yuko Morikawa、Yurika Miyake、Fumio Tsuji、Maki Mizuchi、Hiroshi Suhara、Ken-ichi Fujimura、Masato Horiuchi、Masakazu Ban

  DOI：10.1016/j.bmcl.2008.11.042

  日期：2009.1

  We studied synthetic modifications of N-mercaptoacylamino acid derivatives to develop a new class of leukotriene A4 (LTA4) hydrolase inhibitors. S-(4-Dimethylamino)benzyl-l-cysteine derivative 2a (SA6541) showed inhibitory activity against LTA4 hydrolase (IC50, 270 nM) and selectivity over other metallopeptidases except angiotensin-converting enzyme (ACE, IC50, 520 nM). Modification at the para-substituent

  我们研究了N-巯基酰基氨基酸衍生物的合成修饰，以开发一类新的白三烯A 4（LTA 4）水解酶抑制剂。小号- （4-二甲基氨基）苄基-升-半胱氨酸衍生物2A（SA6541）显示针对LTA抑制活性4水解酶（IC 50，270 nm）的和选择性优于其它金属肽除了血管紧张素转换酶（ACE，IC 50，520 nm）的。化合物2a苯环的对位取代基上的修饰改进了LTA 4水解酶抑制活性以及对ACE的选择性。最后，我们获得了作为有效的和选择性的LTA 4水解酶抑制剂的S-（4-环己基）苯并-1-半胱氨酸衍生物11l和16i。
• SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS
  申请人：Donde Yariv

  公开号：US20090270387A1

  公开（公告）日：2009-10-29

  Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein Y, A, and B are as described. Methods, compositions, and medicaments related thereto are also disclosed.

  包含Y、A和B的化合物或其药用盐或前药的方法、组合物和药物也被揭示。
• Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
  申请人：——

  公开号：US20040034049A1

  公开（公告）日：2004-02-19

  An agent for promoting the proliferation or differentiation of a stem cell and/or neural progenitor cell, comprising a compound represented by Formula: 1 wherein each of R 1 and R 2 is H, a hydrocarbon group or a heterocyclic group, or taken together with the adjacent carbon atom to form a ring, R 3 is H, a hydrocarbon group or a heterocyclic group, W is a group represented by Formula: 2 wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring, R 4 is an acyl group having an aliphatic hydrocarbon group, which is substituted by an aromatic group and may have a further substitutent, or aromatic group, R 5 is H, C 1-6 alkyl or acyl, R 4c is an aromatic group, an aliphatic hydrocarbon group or acyl, and X is O or S; Y is O, S or NH, Ring C is an optionally substituted benzene ring, or a salt or prodrug thereof is provided.

  一种用于促进干细胞和/或神经前体细胞增殖或分化的药剂，包括由公式1表示的化合物，其中R1和R2中的每一个是H、烃基或杂环基，或与相邻的碳原子结合形成环，R3是H、烃基或杂环基，W是由公式2表示的基团，其中环A是可选取代的苯环，环B是可选取代的含氮5-至7元杂环环，R4是取代芳香基的脂肪烃基的酰基，可以有进一步的取代基，或芳香基，R5是H、C1-6烷基或酰基，R4是芳香基、脂肪烃基或酰基，X是O或S；Y是O、S或NH，环C是可选取代的苯环，或其盐或前药。
• Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells
  申请人：Okawa Shigenori

  公开号：US20090012081A1

  公开（公告）日：2009-01-08

  An agent for promoting the proliferation or differentiation of a stem cell and/or neural progenitor cell, comprising a compound represented by Formula: wherein each of R 1 and R 2 is H, a hydrocarbon group or a heterocyclic group, or taken together with the adjacent carbon atom to form a ring, R 3 is H, a hydrocarbon group or a heterocyclic group, W is a group represented by Formula: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring, R 4 is an acyl group having an aliphatic hydrocarbon group, which is substituted by an aromatic group and may have a further substitutent, or aromatic group, R 5 is H, C 1-6 alkyl or acyl, R 4c is an aromatic group, an aliphatic hydrocarbon group or acyl, and X is O or S; Y is O, S or NH, Ring C is an optionally substituted benzene ring, or a salt or prodrug thereof is provided.

  一种用于促进干细胞和/或神经祖细胞增殖或分化的药剂，包括由下式表示的化合物：其中R1和R2中的每一个是H、烃基或杂环基，或与相邻的碳原子结合形成环，R3是H、烃基或杂环基，W是由下式表示的基团：其中环A是可选取代的苯环，环B是可选取代的含氮杂环5-至7-元环，R4是取代芳基的脂肪族烃基的酰基，可以具有进一步的取代基或芳基，或者是芳基，R5是H、C1-6烷基或酰基，R4是芳基、脂肪族烃基或酰基，X是O或S；Y是O、S或NH，环C是可选取代的苯环，或其盐或前药。
• Electrooxidative α-hydroxymethylation of ketones with dimethylformamide as the carbon source
  作者：Jin-Ming Zheng、Yi-Fei Li、Yi-Xiang Pan、Xiao-Dong Hu、Xiao-Xia Ye、Ren-Hao Li

  DOI：10.1039/d3gc00144j

  日期：——

  An environmentally benign electrochemical approach has been developed for the α-hydroxymethylation of ketones using N,N-dimethylformamide as the carbon source for the construction of β-hydroxy ketones. This method does not require metal catalysts or chemical oxidants and proceeded smoothly at room temperature to demonstrate tolerance of a broad range of functional groups.

  开发了一种环境友好的电化学方法，使用N，N-二甲基甲酰胺作为构建 β-羟基酮的碳源，对酮进行 α-羟甲基化。该方法不需要金属催化剂或化学氧化剂，并在室温下顺利进行，以证明对各种官能团的耐受性。